Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Sex-associated differences in the antibody-dependent cellular cytotoxicity antibody response to measles vaccines.

Atabani S, Landucci G, Steward MW, Whittle H, Tilles JG, Forthal DN.

Clin Diagn Lab Immunol. 2000 Jan;7(1):111-3.

2.

Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal.

Aaby P, Samb B, Simondon F, Knudsen K, Seck AM, Bennett J, Whittle H.

Am J Epidemiol. 1993 Nov 1;138(9):746-55.

PMID:
8237989
3.

Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine.

Whittle HC, Campbell H, Rahman S, Armstrong JR.

Lancet. 1990 Oct 27;336(8722):1046-8.

PMID:
1977029
4.

Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.

Markowitz LE, Sepulveda J, Diaz-Ortega JL, Valdespino JL, Albrecht P, Zell ER, Stewart J, Zarate ML, Bernier RH.

N Engl J Med. 1990 Mar 1;322(9):580-7. Erratum in: N Engl J Med 1990 Mar 22;322(12):863.

5.

Child mortality following standard, medium or high titre measles immunization in West Africa.

Knudsen KM, Aaby P, Whittle H, Rowe M, Samb B, Simondon F, Sterne J, Fine P.

Int J Epidemiol. 1996 Jun;25(3):665-73.

PMID:
8671571
6.

Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age.

Martins C, Garly ML, Bale C, Rodrigues A, Njie-Jobe J, Benn CS, Whittle H, Aaby P.

J Infect Dis. 2014 Sep 1;210(5):693-700. doi: 10.1093/infdis/jiu117. Epub 2014 Mar 31.

PMID:
24688075
7.
8.

Comparative efficacy of three measles vaccines in Indian children.

Banerjee K, Shaikh N, Phadke M, Bedekar SS, Rauta SK, Mehta JM.

Indian J Public Health. 1998 Oct-Dec;42(4):113-9.

PMID:
10389523
9.

Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects.

Whittle H, Hanlon P, O'Neill K, Hanlon L, Marsh V, Jupp E, Aaby P.

Lancet. 1988 Oct 8;2(8615):811-4.

PMID:
2902264
10.

Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.

Martins C, Garly ML, Bale C, Rodrigues A, Benn CS, Whittle H, Aaby P.

Vaccine. 2013 Nov 19;31(48):5766-71. doi: 10.1016/j.vaccine.2013.08.044. Epub 2013 Aug 28.

11.

Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Cite Soleil/JHU Project Team.

Job JS, Halsey NA, Boulos R, Holt E, Farrell D, Albrecht P, Brutus JR, Adrien M, Andre J, Chan E, et al.

Pediatr Infect Dis J. 1991 Apr;10(4):303-11.

PMID:
2062626
12.

Comparison of measles virus-specific antibodies with antibody-dependent cellular cytotoxicity and neutralizing functions.

Forthal DN, Landucci G, Katz J, Tilles JG.

J Infect Dis. 1993 Oct;168(4):1020-3.

PMID:
8376813
13.

The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune response in infants.

Hussey GD, Goddard EA, Hughes J, Ryon JJ, Kerran M, Carelse E, Strebel PM, Markowitz LE, Moodie J, Barron P, Latief Z, Sayed R, Beatty D, Griffin DE.

J Infect Dis. 1996 Jun;173(6):1320-6.

PMID:
8648203
14.

Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infants.

Berry S, Hernandez H, Kanashiro R, Campos M, Azabache V, Gomez G, Gutierrez M, Weirs B, De Quadros C, Halsey N.

Pediatr Infect Dis J. 1992 Oct;11(10):822-7.

PMID:
1408479
15.

Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines.

Whittle H, Aaby P, Samb B, Cissé B, Kanteh F, Soumaré M, Jensen H, Bennett J, Simondon F.

Pediatr Infect Dis J. 1999 Jan;18(1):53-7.

PMID:
9951981
16.

Expanded programme on immunization (EPI). Safety of high titre measles vaccines.

[No authors listed]

Wkly Epidemiol Rec. 1992 Nov 27;67(48):357-61. English, French.

PMID:
1449986
17.

Long term impact of high titer Edmonston-Zagreb measles vaccine on T lymphocyte subsets.

Lisse IM, Aaby P, Knudsen K, Whittle H, Andersen H.

Pediatr Infect Dis J. 1994 Feb;13(2):109-12.

PMID:
8190534
18.

Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.

Dilraj A, Sukhoo R, Cutts FT, Bennett JV.

Vaccine. 2007 May 22;25(21):4170-4. Epub 2007 Mar 20.

PMID:
17408818
19.

Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response.

Sabin AB, Flores Arechiga A, Fernández de Castro J, Albrecht P, Sever JL, Shekarchi I.

JAMA. 1984 May 11;251(18):2363-71.

PMID:
6368888
20.

Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine.

Bolotovski VM, Grabowsky M, Clements CJ, Albrecht P, Brenner ER, Zargaryantzs AI, Litvinov SK, Mikheyeva IV.

Int J Epidemiol. 1994 Oct;23(5):1069-77.

PMID:
7860158

Supplemental Content

Support Center